Presentation TCT 2016 Can CT Identify Vulnerable Plaque and Eventually Predict Myocardial Infarction? Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min November 01, 2016
Presentation TCT 2016 My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer Presenter: Gregg W. Stone, Ron Waksman, John A. Ambrose November 01, 2016
Presentation TCT 2016 Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque Presenter: Gregg W. Stone, Ron Waksman, Jonathan Leor November 01, 2016
Presentation TCT 2016 Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner? Presenter: Gregg W. Stone, Ron Waksman, Sanjit S. Jolly November 01, 2016
Presentation TCT 2016 To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT Presenter: Gregg W. Stone, Ron Waksman, Seung-Jung Park November 01, 2016
Presentation TCT 2016 Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?! Presenter: Gregg W. Stone, Ron Waksman, Vasim Farooq November 01, 2016
Presentation TCT 2016 Diagnosis and Treatment of Erosion in ACS: The EROSION Study Presenter: John A. Ambrose, Peter H. Stone, Ik-Kyung Jang November 01, 2016
Presentation TCT 2016 Detecting and Differentiating Plaque Erosion vs Rupture and Does It Matter? Presenter: John A. Ambrose, Peter H. Stone, Giulio Guagliumi November 01, 2016
Presentation TCT 2016 Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal Presenter: John A. Ambrose, Peter H. Stone, Guillermo Tearney November 01, 2016
Presentation TCT 2016 NIRS Detection of Vulnerable Plaque: The Story Is Intensifying Presenter: John A. Ambrose, Peter H. Stone, David Erlinge November 01, 2016
Presentation TCT 2016 What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia? Presenter: John A. Ambrose, Peter H. Stone November 01, 2016
Presentation TCT 2016 The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer Presenter: John A. Ambrose, Peter H. Stone, James E. Muller November 01, 2016
Presentation TCT 2016 Continued Search for the Vulnerable Plaque: Are We Any Closer? Presenter: Justin E. Davies, Ran Kornowski, Farouc Jaffer October 31, 2016
Presentation TCT 2016 DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor! Presenter: Ran Kornowski, Michel R. Le May, Tej Sheth October 31, 2016
Presentation TCT 2016 TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in Diabetic Patients Compared to Non-Diabetic Ones. Study With 3D Intravascular Ultrasound and Virtual Histology Presenter: Farouc Jaffer, Amir Lerman, Tomas Kovarnik October 31, 2016
Presentation TCT 2016 TCT 95: The Interplay Between Features of Plaque Vulnerability and Hemodynamic Relevance of Coronary Artery Stenoses Presenter: Farouc Jaffer, Amir Lerman, Sabahattin Umman October 31, 2016
Presentation TCT 2016 TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study Presenter: Farouc Jaffer, Amir Lerman, Elvin Kedhi October 31, 2016
Presentation TCT 2016 TCT 93: Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease During 4.3 Year Follow-up Presenter: Farouc Jaffer, Amir Lerman, Eric Boersma October 31, 2016
News Conference News TCT 2016 YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients Michael O'Riordan October 29, 2016
News Daily News Anger, Physical Exertion May Up Risk of Acute MI for Some—but Not All L.A. McKeown October 12, 2016